Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 5, 2006, Pages 1862-1868

  Watanabe, Masanao ^a   Kondo, Shoichi ^a   Mizuno, Ken ^a   Yano, Wataru ^a   Nakao, Hiroshi ^a   Hattori, Yukio ^a   Kimura, Kazuhiro ^b   Nishida, Teruo ^b  

^a KOWA COMPANY LTD   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; ENZYME INHIBITOR; UROKINASE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA EPITHELIUM; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING; ZYMOGRAPHY; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; INJURY; MALE; METABOLISM; PHYSIOLOGY; RABBIT; UPREGULATION;

ANIMALS; ANNEXIN A5; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; MALE; RABBITS; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 33744732720     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0591     Document Type: Article

References (56)

1. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1994;1197:63-93.
2. Liemann S, Benz J, Huber R. Calcium-binding proteins: annexins. In: Carafoli E, Klee CB, eds. Calcium as a Cellular Regulator. New York: Oxford University Press; 1999:100-122.
3. Reutelingsperger CPM. Annexins: key regulators of haemostasis, thrombosis, and apoptosis. Thromb Haemost. 2001;86:413-419.
4. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331-371.
5. Iwasaki A, Suda M, Nakao H, et al. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein. J Biochem (Tokyo). 1987;102:1261-1273.
6. 2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J. 1990;266:195-200.
7. 2 and phospholipase C. Acta Obstetr Gynaecol Jpn. 1992;44:793-799.
8. 2+-binding site in the mechanism of inhibition. J Biol Chem. 1997;272:10474-10482.
9. Schlaepfer DD, Jones J, Haigler HT. Inhibition of protein kinase C by annexin V. Biochemistry. 1992;31:1886-1891.
10. Dubois T, Mira JP, Feliers D, Solito E, Russo-Marie F, Oudinet JP. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J. 1998;330:1277-1282.
11. Rojas E, Pollard HB, Haigler HT, Parra C, Burns AL. Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem. 1990;265:21207-21215.
12. Berendes R, Burger A, Voges D, Demange P, Huber R. Calcium influx through annexin V ion channels into large unilamellar vesicles measured with fura-2. FEBS Lett. 1993;317:131-134.
13. Kirsch T, Harrison G, Golub EE, Nah HD. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem. 2000;275:35577-35583.
14. Kirsch T. Annexins and tissue mineralization: matrix vesicles, ion channel activity of annexins and annexin V/collagen interactions. In: Bandorowicz-Pikula J, ed. Annexins: Biological Importance and Annexin-Related Pathologies. New York: Kluwer Academic/Plenum; 2003:172-181.
15. Giambanco I, Pula G, Ceccarelli P, Bianchi R, Donato R. Immunohistochemical localization of annexin V (CaBP33) in rat organs. J Histochem Cytochem. 1991;39:1189-1198.
16. Nakao H, Watanabe M, Maki M. A new function of calphobindin I (annexin V). Promotion of both migration and urokinase-type plasminogen activator activity of normal human keratinocytes. Eur J Biochem. 1994;223:901-908.
17. Suzuki K, Saito J, Yanai R, et al. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res. 2003;22:113-133.
18. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84:359-369.
19. Sheetz MP, Felsenfeld DP, Galbraith CG. Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol. 1998;8:51-54.
20. Berman M. The pathogenesis of corneal epithelial defects. Acta Ophthalmol. 1989;192:55-64.
21. Hayashi K, Berman M, Smith D, el-Ghatit A, Pease S, Kenyon KR. Pathogenesis of corneal epithelial defects: role of plasminogen activator. Curr Eye Res. 1991;10:381-398.
22. Gudewicz PW, Gilboa N. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun. 1987;147:1176-1181.
23. Del Rosso M, Anichini E, Pedersen N, et al. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun. 1993;190:347-352.
24. Okada SS, Grobmyer SR, Barnathan ES. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler Thromb Vasc Biol. 1996;16:1269-1276.
25. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 1996;15:1572-1582.
26. Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb Haemost. 1999;82:298-304.
27. Morimoto K, Mishima H, Nishida T, Otori T. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. Thromb Haemost. 1993;69:387-391.
28. Watanabe M, Yano W, Kondo S, et al. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci. 2003;44:3332-3338.
29. Gipson IK, Grill SM. A technique for obtaining sheets of intact rabbit corneal epithelium. Invest Ophthalmol Vis Sci. 1982;23:269-273.
30. Watanabe K, Nakagawa S, Nishida T. Chemotactic and haptotactic activities of fibronectin for cultured rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci. 1988;29:572-577.
31. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980;102:196-202.
32. Tozser J, Berta A. Urokinase-type plasminogen activator in rabbit tears. Comparison with human tears. Exp Eye Res. 1990;51:33-37.
33. Kato H, Adachi N, Ohno Y, Iwanaga S, Takada K, Sakakibara S. New fluorogenic peptide substrates for plasmin. J Biochem (Tokyo). 1980;88:183-190.
34. Moses RA, Parkinson G, Schuchardt R. A standard large wound of the corneal epithelium in the rabbit. Invest Ophthalmol Vis Sci. 1979;18:103-106.
35. Petroutsos G, Courty J, Guimaraes R, et al. Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res. 1984;3:593-598.
36. Crosson CE, Klyce SD, Beuerman RW. Epithelial wound closure in the rabbit cornea: a biphasic process. Invest Ophthalmol Vis Sci. 1986;27:464-473.
37. Nishida T, Nakamura M, Mishima H, Otori T, Hikida M. Interleukin 6 facilitates corneal epithelial wound closure in vivo. Arch Ophthalmol. 1992;110:1292-1294.
38. Reidy JJ, Zarzour J, Thompson HW, Beuerman RW. Effect of topical beta blockers on corneal epithelial wound healing in the rabbit. Br J Ophthalmol. 1994;78:377-380.
39. Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
40. Sigemitsu T, Shimizu Y, Majima Y. Effects of mucin ophthalmic solution on epithelial wound healing in rabbit cornea. Ophthalmic Res. 1997;29:61-66.
41. Rieck P, Assouline M, Savoldelli M, et al. Recombinant human basic fibroblast growth factor (Rh-bFGF) in three different wound models in rabbits: corneal wound healing effect and pharmacology. Exp Eye Res. 1992;54:987-998.
42. Wilson SE, He YG, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
43. Zhang Y, Akhtar RA. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci. 1997;38:1139-1148.
44. Morioka S, Lazarus GS, Baird JL, Jensen PJ. Migrating keratinocytes express urokinase-type plasminogen activator. J Invest Dermatol. 1987;88:418-423.
45. Nguyen DH, Webb DJ, Catling AD, et al. Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc: rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem. 2000;275:19382-19388.
46. Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinasetype plasminogen activator-stimulated cell migration. J Biol Chem. 2002;277:12479-12485.
47. Nakao H, Nagoya T, Iwasaki A, et al. An enzyme-linked immunosorbent assay system for quantitative determination of calphobindin I, a new placental anticoagulant protein, and its application to various specimens. Chem Pharm Bull. 1990;38:1957-1960.
48. Chapman LP, Epton MJ, Buckingham JC, Morris JF, Christian HC. Evidence for a role of the adenosine 5́-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology. 2003;144:1062-1073.
49. Peterson EA, Sutherland MR, Nesheim ME, Pryzdial EL. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J Cell Sci. 2003;116:2399-2408.
50. Danielsen EM, van Deurs B, Hansen GH. "Nonclassical" secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry. 2003;42:14670-14676.
51. Rescher U, Gerke V. Annexins: unique membrane binding proteins with diverse functions. J Cell Sci. 2004;117:2631-2639.
52. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39-51.
53. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193.
54. Dillon SR, Mancini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 2000;164:1322-1332.
55. Dillon SR, Constantinescu A, Schlissel MS. Annexin V binds to positively selected B cells. J Immunol. 2001;166:58-71.
56. Wilson HL, Francis SE, Dower SK, Crossman DC. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J Immunol. 2004;173:1202-1208.